Ham A, Lin S, Tse A, Thurkauf M, McGowan T, Jorin L
Nat Commun. 2025; 16(1):2220.
PMID: 40044687
PMC: 11882927.
DOI: 10.1038/s41467-025-57487-1.
Cossins J, Kozma I, Canzonetta C, Hawkins A, Beeson D, Sepulveda P
Brain Commun. 2025; 7(1):fcaf046.
PMID: 39944742
PMC: 11814498.
DOI: 10.1093/braincomms/fcaf046.
Barden J, Kosloski O, Jadidian A, Akaaboune M
J Cell Sci. 2024; 137(24).
PMID: 39575567
PMC: 11795291.
DOI: 10.1242/jcs.262303.
Li Y, Badawi Y, Meriney S
Cells. 2024; 13(20.
PMID: 39451202
PMC: 11506802.
DOI: 10.3390/cells13201684.
Chen H, Yeo H, Huang Y, Tsai L, Lai H, Tsao Y
Skelet Muscle. 2024; 14(1):17.
PMID: 39044305
PMC: 11267858.
DOI: 10.1186/s13395-024-00349-z.
Neuronal LRP4 directs the development, maturation and cytoskeletal organization of Drosophila peripheral synapses.
DePew A, Bruckner J, OConnor-Giles K, Mosca T
Development. 2024; 151(11).
PMID: 38738619
PMC: 11190576.
DOI: 10.1242/dev.202517.
The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice.
Sun S, Shen Y, Zhang X, Ding N, Xu Z, Zhang Q
Mol Ther. 2024; 32(7):2176-2189.
PMID: 38734896
PMC: 11286808.
DOI: 10.1016/j.ymthe.2024.05.016.
Identification of exosome-related gene signature as a promising diagnostic and therapeutic tool for breast cancer.
Chen Q, Zhou Q
Heliyon. 2024; 10(8):e29551.
PMID: 38665551
PMC: 11043961.
DOI: 10.1016/j.heliyon.2024.e29551.
MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets.
Dziadkowiak E, Baczynska D, Waliszewska-Prosol M
Cells. 2024; 13(6.
PMID: 38534400
PMC: 10968960.
DOI: 10.3390/cells13060556.
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors.
Pekkarinen M, Nordfors K, Uusi-Makela J, Kytola V, Hartewig A, Huhtala L
Life Sci Alliance. 2024; 7(6).
PMID: 38499326
PMC: 10948937.
DOI: 10.26508/lsa.202302088.
Calcium-binding protein 7 expressed in muscle negatively regulates age-related degeneration of neuromuscular junctions in mice.
Eguchi T, Tezuka T, Watanabe Y, Inoue-Yamauchi A, Sagara H, Ozawa M
iScience. 2024; 27(2):108997.
PMID: 38327785
PMC: 10847746.
DOI: 10.1016/j.isci.2024.108997.
Peroxisome proliferator-activated receptor γ coactivator 1α regulates downstream of tyrosine kinase-7 (Dok-7) expression important for neuromuscular junction formation.
Sugimoto T, Sakamaki C, Kimura T, Eguchi T, Miura S, Kamei Y
Sci Rep. 2024; 14(1):1780.
PMID: 38245592
PMC: 10799880.
DOI: 10.1038/s41598-024-52198-x.
Myosin Va: Capturing cAMP for synaptic plasticity.
Rudolf R
Front Physiol. 2024; 14:1342994.
PMID: 38239886
PMC: 10794446.
DOI: 10.3389/fphys.2023.1342994.
, a target of miR-299-5p, suppresses the progression of bladder cancer.
Tian X, Liu D, He P, Li L, Wang Y, Qiu M
Aging (Albany NY). 2023; 15(23):14306-14322.
PMID: 38095644
PMC: 10756110.
DOI: 10.18632/aging.205304.
Homozygous Duplication in the in a Family with Congenital Myasthenic Syndrome 4C: 18-Year Follow Up.
Almatrafi A, Alluqmani M, Basit S
Biomedicines. 2023; 11(11).
PMID: 38001983
PMC: 10668953.
DOI: 10.3390/biomedicines11112983.
Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7.
Huang Y, Crick H, Chaytow H, van der Hoorn D, Alhindi A, Jones R
Mol Ther Nucleic Acids. 2023; 33:617-628.
PMID: 37637210
PMC: 10457688.
DOI: 10.1016/j.omtn.2023.07.036.
NMJ-related diseases beyond the congenital myasthenic syndromes.
Navarro-Martinez A, Vicente-Garcia C, Carvajal J
Front Cell Dev Biol. 2023; 11:1216726.
PMID: 37601107
PMC: 10436495.
DOI: 10.3389/fcell.2023.1216726.
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.
Vakrakou A, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S
Front Immunol. 2023; 14:1212757.
PMID: 37564637
PMC: 10410455.
DOI: 10.3389/fimmu.2023.1212757.
Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex.
Xie T, Xu G, Liu Y, Quade B, Lin W, Bai X
Proc Natl Acad Sci U S A. 2023; 120(23):e2300453120.
PMID: 37252960
PMC: 10266037.
DOI: 10.1073/pnas.2300453120.
Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment.
McMacken G, Whittaker R, Wake R, Lochmuller H, Horvath R
J Neurol. 2023; 270(6):3112-3119.
PMID: 36869887
PMC: 10188419.
DOI: 10.1007/s00415-023-11643-z.